Medicinal Cannabis Applications Target the Development of Enhanced Therapies and Treatments for Various Health …

Recent studies concerning the therapeutic attributes of Cannabidiol (CBD) have pointed to growing evidence to suggest that it could help in the treatment of anxiety-related and other health disorders. With recent research and development aimed at identifying new therapies and treatments for various ailments, companies are focusing on improving therapies such as: India Globalization Capital, Inc. (NYSE: IGC), INSYS Therapeutics, Inc. (NASDAQ: INSY), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), Terra Tech Corp. (OTC:TRTC) and Cannabics Pharmaceuticals Inc. (OTC:CNBX).

India Globalization Capital, Inc. (NYSE-MKT:IGC) today announces its provisional patent filing (IGC-506) for the treatment of multiple types of eating disorders by a method and combination of cannabis extracts and other compounds. IGC-506 is being developed for both human and veterinary use, should this filing progress to the issuance of a patent. Read this and more news for IGC at: http://marketnewsupdates.com/news/igc.html

“The development of cannabis-based combination therapies represents a large,

... read more at: http://www.prnewswire.com/news-releases/medicinal-cannabis-applications-target-the-development-of-enhanced-therapies-and-treatments-for-various-health-disorders-616707154.html

by